Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

validate-confirms-high-sensitivity-of-the-cadscorsystem

05/05/2020
For the first time, the usage of the CADScor® System in a high prevalence cohort is described by M. Renker et al. This prospective randomized cohort was designed as technical study to confirm predicted sensitivity and specificity in a high prevalence patie...

Acarix prepares the CADScor®System for the the US market

03/03/2020
Per Person,  Acarix CEO presented the CADScor® System at the Emerging Medtech Summit in California, USA, last month. Acarix gained interest from several parties interested to support our journey towards presence in the US market.      Last week we had ...

New Partnership and Distributors in Austria and Switzerland

13/01/2020
As an important part of our continued work in creating a better market access for the CADScor (R) System in our key markets, we are happy to announce the following new partnership and Distributors; Neucomed in Austria and Bodenwinkler in Switzerland. This ...